Last reviewed · How we verify
Anticoagulant-Induced Prothrombin Deficiency
Approved treatments
- phytomenadione · Instituto Mexicano del Seguro Social
- PHYTONADIONE
- Phylloquinone · Guy's and St Thomas' NHS Foundation Trust
Clinical guidelines
- FDA label — 1L
Phytonadione injectable emulsion is indicated for hypoprothrombinemia due to antibacterial therapy. - FDA label — 1L
Phytonadione injectable emulsion is indicated for anticoagulant-induced prothrombin deficiency caused by coumarin or indanedione derivatives. - FDA label — 1L
Phytonadione injectable emulsion is indicated for the prophylaxis and therapy of hemorrhagic disease of the newborn. - FDA label — 1L
Phytonadione injectable emulsion is indicated for hypoprothrombinemia secondary to factors limiting absorption or synthesis of Vitamin K, such as obstructive jaundice, biliary fistula, sprue, ulcerative colitis, celiac disease, intestinal resection, cystic fibrosis of the pancreas, and regional enteritis. - FDA label — 1L
Phytonadione injectable emulsion is indicated for other drug-induced hypoprothrombinemia where it is definitely shown that the result is due to interference with phytonadione injectable emulsion metabolism, such as with salicylates.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Anticoagulant-Induced Prothrombin Deficiency patent landscape — cliff calendar, originator estates, attackable patents
- Anticoagulant-Induced Prothrombin Deficiency treatment landscape brief
- Anticoagulant-Induced Prothrombin Deficiency treatment updates RSS
Frequently asked questions about Anticoagulant-Induced Prothrombin Deficiency
What drugs treat Anticoagulant-Induced Prothrombin Deficiency?
Tracked treatments include phytomenadione, PHYTONADIONE, Phylloquinone.
What is the treatment for Anticoagulant-Induced Prothrombin Deficiency?
Standard treatment for Anticoagulant-Induced Prothrombin Deficiency includes phytomenadione, PHYTONADIONE, Phylloquinone. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Anticoagulant-Induced Prothrombin Deficiency?
FDA label publishes guidelines for Anticoagulant-Induced Prothrombin Deficiency. 5 guideline references tracked.
Related
- Treatment landscape: Anticoagulant-Induced Prothrombin Deficiency patent cliff · Anticoagulant-Induced Prothrombin Deficiency CI report
- Treatment: phytomenadione · Instituto Mexicano del Seguro Social
- Treatment: PHYTONADIONE
- Treatment: Phylloquinone · Guy's and St Thomas' NHS Foundation Trust
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing